IBB.US iShares Biotechnology ETF

- USD
No recent price
Total assets
11.4B
Expense ratio
0.46%
Dividend yield
0.16%
1-year return
+33.04%
Holdings
236
Since
2001

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does IBB.US invest in?

  • Mostly US stocks (95.5%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (92.1%)
  • Top 3 holdings: 25.4% of the fund

Asset allocation

  • US stocks 95.5%
  • Non-US stocks 5.9%
  • Cash 0.1%

Top holdings

All holdings, sectors and regions

iShares Biotechnology ETF performance

Sharpe ratio 1.03
This year
+27.90%
1 year
+33.04%
3 years
+23.63%
5 years
+7.39%

Volatility 18.4% over 1 year and 18.6% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

IBB.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About iShares Biotechnology ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Full fund profile